Closed blood sampling systems are the needle-free blood sampling systems, which reduces wastage of blood, while minimizing the risk of infectious disease transmission. Closed blood sampling systems aim at increasing the efficacy of the process of blood sampling, especially in case of the critically-ill patients affected by trauma or severe injuries. The system of closed blood sampling includes a reservoir that allows storage of blood, minimizing repeated isolation of blood from the sampling site including antecubital area, wrist foot, or hand. The factors including rising prevalence of trauma and surgeries along with benefits of the closed blood sampling systems over the traditional techniques, are expected to drive the global closed blood sampling market.
Furthermore, implementation of closed blood sampling systems notably decreases iatrogenic anemia, in turn decreasing the requirement for the blood transfusions along with reducing possible risks of negative effects of transfusion. However, dearth of implementation of the process along with dearth of professionals is expected to restrain the global closed blood sampling system market growth over the forecast period.
Request for Analysis of COVID-19 Impact on Closed Blood Sampling System Market –
https://www.coherentmarketinsights.com/insight/request-sample/1642
Rising number of surgical procedures are expected to drive growth of the global closed blood sampling system market over the forecast period. In 2012, as per the estimated from the World Health Organization (WHO), over 266.2 -359.5 Mn surgeries were carried out, which was over 38% high than the past years which is projected to rise over the forecast period. Therefore, rising number of emergency cases and surgeries, and high demands for blood transfusion surges the closed blood sampling system demands. Moreover, National Center for Biotechnology Information (NCBI) studies reported that patients hospitalized in ICU are mainly anemic with over 30-37% of patients receiving blood transfusions while ICU, this also states the increasing needs for the closed blood sampling systems.
Furthermore, rising prevalence of trauma as well as some disease conditions including cancer, diabetes, HIV/AIDS, rare diseases, anemia, and coronary heart disease, are factors expected to drive growth of the global closed blood sampling system market over the forest period. As per the 2016 data findings by Centers for Disease Control and Prevention (CDC), around 26,203 Lyme disease cases were registered in the U.S. from 2006 to 2016. In 2015, as per the CDC over 10,265 deaths were recorded owing to alcohol-impaired accidents, accounted for over 29% of the entire deaths related to traffic within the U.S.
In conventional systems of blood sampling, blood sample is taken by removing the stopcock cap, increasing the risks of the acquired infection in blood stream while sampling. Furthermore, in case of the conventional sampling methods the blood that is unused is wasted. However, the closed blood sampling system is the solution for such problems. Moreover, the article from National Center for Biotechnology Information (NCBI) suggests that hematocrit and hemoglobin counts show minimal fluctuations after the blood sampling through closed blood sampling system.
Request PDF Brochure Report –
https://www.coherentmarketinsights.com/insight/request-pdf/1642
Closed blood sampling system is also used for pediatric patients, due to ease of implementation, significant reduction within blood loss, and low cost. The intensive care unit (ICU) patients get blood transfusion for treating low levels of hemoglobin in patients having severe illness. However, inadequate methods of blood transfusion are associated mostly with increased mortality and morbidity risk. Several government regulatory bodies have suggested guidelines to reduce the usage of the blood transfusion. The Canadian Medical Association (CMA) guidelines in 2008 issued in the Canadian Medical Association Journal (CMAL), published in January 2008, for minimizing the blood transfusion usage in severely ill patients where the method of closed blood sampling systems would be to comply with the regulations.
Major players functioning in the global closed blood sampling system market are Edwards Lifesciences Crop, Smiths Medical, ICU Medical, Inc., CardioMed Supplies Inc., Utah Medical Products, Inc., Argon Medical Devices, Inc., Velano Vascular, Inc., fannin Ltd., Ashcon International Inc., Merit Medical Systems, Inc., and others.
Major players in the global closed blood sampling system market are focused on strategies of organic growth, for enhancing its share and retaining its competence in the global closed blood sampling system market. For instance, Velano Vascular, Inc., a company of medical device manufacturing needle-less, vascular device to collect blood, in January 2016, received approval from the U.S. Food and Drug Administration (FDA) for the modified version of the needle-free device of blood draw. Novel Velano device is introduced for reducing blood draw associated discomfort and anxiety in patients along with providing a safe work environment among healthcare professionals.
Reasons to Purchase this Report
Current and future of global Closed Blood Sampling System market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
Regions/countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players
Buy This Complete A Business Report With Flat US $2000 Off @
https://www.coherentmarketinsights.com/promo/buynow/1642
Global Closed Blood Sampling System Market Taxonomy:
Based on Product Type:
- Blood Sampling Accessories
- Blood Sampling System
Based on Application:
- Treatment
- Diagnostic
Based on End Users:
- Surgical Clinics
- Blood Banks
- Hospitals and Nursing Homes
- Research and Academic Organizations
- Diagnostic Centers
- Others
Based on Geography:
- North America
- Europe
- Latin America
- Asia Pacific
- Africa
- Middle East
Major Point Answered in Closed Blood Sampling System Market Research Study are:
What will be the progress rate of the Closed Blood Sampling System Market for the conjecture period, 2020-2027?
What are the prominent factors driving the Closed Blood Sampling System Market across different regions?
Who are the major vendors dominating the Closed Blood Sampling System industry and what are their winning strategies?
What will be the market scope for the estimated period?
What are the major trends shaping the expansion of the industry in the coming years?
What are the challenges faced by the Closed Blood Sampling System Market?
Actual Numbers & In-Depth Analysis, Business opportunities, Market Size Estimation Available in Full Report.
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837